Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning

被引:72
作者
Denkbas, EB
Seyyal, M
Piskin, E
机构
[1] Hacettepe Univ, Dept Chem, Div Biochem, TR-06532 Ankara, Turkey
[2] Eczacibasi Pharmaceut, Luleburgaz, Turkey
[3] Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey
[4] Hacettepe Univ, Bioengn Div, Ankara, Turkey
[5] Hacettepe Univ, TUBITAK Ctr Excellence Polymer Biomat POLBITEK, Ankara, Turkey
关键词
chitosan scaffolds; 5-fluorouracil; drug loading and release;
D O I
10.1016/S0376-7388(00)00314-8
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
5-Fuorouracil (5-FU) loaded scaffolds composed of chitosan fibers were prepared by a modified wet spinning technique. Chitosan aqueous solutions in acetic acid were used. Ethyl alcohol was the main component in the precipitation medium in which glutaraldehyde was utilized as the cross-linker. The scaffolds were quite swellable. Equilibrium swellings (upto about 56.8% swelling ratio) were achieved in about 90 min. 5-FU loading, which was achieved during fiber formation was low and was in the range of 0.21-7.55 mg 5-FU/g chitosan. Drug release, which was investigated in phosphate buffer at physiological conditions, was high at the initial period (in the first 90 min) in parallel to swelling, and reached almost a constant but at a much slower rate after that. Much slower release rates were observed in the initial period when the cross-linker density was high. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 24 条
  • [1] Budavari S., 1989, The merck index: an encyclopedia of chemicals, drug, and biologicals
  • [2] GENNARO AR, 1990, REMINGTONIS PHARM SC, V1151
  • [3] MEMBRANE FORMATION BY INTERFACIAL CROSS-LINKING OF CHITOSAN FOR MICROENCAPSULATION OF LACTOCOCCUS-LACTIS
    GROBOILLOT, AF
    CHAMPAGNE, CP
    DARLING, GD
    PONCELET, D
    NEUFELD, RJ
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1993, 42 (10) : 1157 - 1163
  • [4] BURN WOUND CLOSURE WITH CULTURED AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS ATTACHED TO A COLLAGEN-GLYCOSAMINOGLYCAN SUBSTRATE
    HANSBROUGH, JF
    BOYCE, ST
    COOPER, ML
    FOREMAN, TJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (15): : 2125 - 2130
  • [5] PROTEASE IMMOBILIZATION ONTO POROUS CHITOSAN BEADS
    HAYASHI, T
    IKADA, Y
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 1991, 42 (01) : 85 - 92
  • [6] FIBROBLAST AND EPITHELIAL-CELL INTERACTIONS WITH SURFACE-TREATED IMPLANT MATERIALS
    JANSEN, JA
    VANDERWAERDEN, JPCM
    DEGROOT, K
    [J]. BIOMATERIALS, 1991, 12 (01) : 25 - 31
  • [7] Kane JB., 1996, Biomaterials science: an introduction to materials in medicine, P360
  • [8] KNORR D, 1985, FOOD TECHNOL-CHICAGO, V39, P135
  • [9] KRAJEWSKA B, 1990, J CHEM TECHNOL BIOT, V48, P337
  • [10] Design of microencapsulated chitosan microspheres for colonic drug delivery
    Lorenzo-Lamosa, ML
    Remunan-Lopez, C
    Vila-Jato, JL
    Alonso, MJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) : 109 - 118